NovaBridge Biosciences American Depositary Shares
NBP
48 hedge funds and large institutions have $55.9M invested in NovaBridge Biosciences American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 8 closing their positions.
4% more call options, than puts
Call options by funds: $29K | Put options by funds: $28K
1.09% less ownership
Funds ownership: 10.83% → 9.74% (-1.1%)
9% less funds holding
Funds holding: 53 → 48 (-5)
22% less capital invested
Capital invested by funds: $71.6M → $55.9M (-$15.7M)
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$360K |
| 2 |
Two Sigma Investments
New York
|
+$351K |
| 3 |
Two Sigma Advisers
New York
|
+$221K |
| 4 |
Renaissance Technologies
New York
|
+$124K |
| 5 |
JP Morgan Chase
New York
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.39M |
| 2 |
Morgan Stanley
New York
|
-$2.16M |
| 3 |
Barclays
London,
United Kingdom
|
-$1.02M |
| 4 |
BA
Bridgewater Associates
Westport,
Connecticut
|
-$524K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$353K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Jane Street
New York
| – | -$87.6K | -25,319 | Closed |
|
52
D.E. Shaw & Co
New York
| – | -$59.7K | -17,266 | Closed |
|
53
Northern Trust
Chicago,
Illinois
| – | -$45.1K | -13,033 | Closed |
|
|
XT
54
XTX Topco
George Town,
Cayman Islands
| – | -$36.6K | -10,579 | Closed |
|
|
BTI
55
Blue Trust Inc
Alpharetta,
Georgia
| – | -$42 | -13 | -25% |
|
NBP Hedge Fund Activity: Q2 2023 in Review
48 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2023, worth a combined $55.9M — down 22% from $71.6M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NBP and 4 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 12 added.
The largest buyer was BlackRock, adding an estimated $360K. The largest seller was Millennium Management, exiting entirely with an estimated $2.39M sold.
- 48 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2023, down from 53 in Q1 2023.
- Funds reported $55.9M of NovaBridge Biosciences American Depositary Shares stock for Q2 2023, down 22% quarter-over-quarter.
- 4 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2023 and 8 closed out, a net change of -4 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2023 was BlackRock, an estimated $360K added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2023 was Millennium Management, an estimated $2.39M sold.
Based on aggregated 13F filings for Q2 2023.